Effectiveness and safety of polyresullen in the treatment of menopausal genitourinary syndrome. Controlled and randomized study
Efectividad y seguridad del policresuleno en el tratamiento del síndrome genitourinario de la menopausia. Estudio controlado y aleatorizado Effectiveness and safety of polyresullen in the treatment of menopausal genitourinary syndrome. Controlled and randomized study
How to Cite
Download Citation
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Show authors biography
Most read articles by the same author(s)
- Franklin jose espitia de la hoz, Cornual ectopic pregnancy; Report of three cases , Archivos de Medicina : Vol. 14 No. 2
- Franklin José Espitia de la Hoz, Non-hormonal treatment of genitourinary syndrome of menopause , Archivos de Medicina : Vol. 21 No. 2 (2021): .
- Franklin Jose Espitia De La Hoz, Hormone replacement therapy combined with testosterone for the treatment of hypoactive sexual desire disorder in climacteric women , Archivos de Medicina : Vol. 20 No. 1 (2020)
- Franklin José Espitia De la Hoz, Effectiveness and safety of polyresullen in the treatment of menopausal genitourinary syndrome. Controlled and randomized study , Archivos de Medicina : Vol. 21 No. 1 (2021): .
- Franklin José Espitia De La Hoz, Evaluation of the prevalence of sexual dysfunction in female physicians, from the Eje Cafetero colombiano, in the climacteric stage. , Archivos de Medicina : Vol. 17 No. 1
- Franklin Jose Espitia De La Hoz, The ambivalence of voluntary termination of pregnancy , Archivos de Medicina : Vol. 18 No. 1
- Franklin Jose Espitia De La Hoz, Promestriene: Evaluation of the impact on serum estradiol levels in women with breast cancer and genitourinary syndrome of menopause. Armenia, Colombia, 2017-2018 , Archivos de Medicina : Vol. 22 No. 2 (2022): .
Objective: to evaluate the effectiveness and safety of policresulen against estriol and vaginal lubricant in the treatment of menopausal genitourinary syndrome in women from Armenia (Quindío, Colombia). Materials and methods: in women diagnosed with genitourinary menopausal syndrome, a randomized, three-blind, controlled clinical trial was conducted. Three groups were assigned (estriol, n = 86, vaginal lubricant, n = 83 and policresulen, n = 82). The main indicator parameter of effectiveness was the elevation of the vaginal health index (ISV) score, improvement in sexual function according to the Abbreviated Female Sexual Function Index-6 (IFSFA-6), percentage of improvement in symptoms and incidence of adverse effects. Results: the effectiveness was greater with the use of estriol, followed by policresulen and less with the vaginal lubricant (92.82%, 75.69% and 63.74%, respectively, p = 0.012); Differences were also found in the improvement of sexual function, according to IFSFA-6 scores [29.29 ± 6.23 (estriol), 28.66 ± 6.12 (policresulen) and 25.38 ± 6.27 (vaginal lubricant), p = 0.021], with differences in the percentage of both improvement in symptoms and in the presentation of adverse effects (p = 0.001). Conclusions: Polycresullen has a significant effectiveness in the treatment of genitourinary syndrome of menopause, superior compared to vaginal lubricant, but inferior when compared to estriol. The presence of adverse effects is evident, greater with estriol, followed by policresulen and then vaginal lubricant, without questioning the remarkable safety profile of polyresulin.
Article visits 2302 | PDF visits 117
Downloads
- Portman DJ, Gass ML. Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. J Sex Med 2014; 11(12):2865-2872. DOI: https://doi.org/10.1111/jsm.12686
- Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, Khan SA. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol 2016; 215(6):704-711. DOI: https://doi.org/10.1016/j.ajog.2016.07.045
- Espitia-De la Hoz FJ. Prevalence of genitourinary syndrome of menopause and impact on sexuality of women in Quindío (Colombia), 2013-2016. Rev Colomb Obstet Ginecol 2018; 69(4):249-59. DOI: https://doi.org/10.18597/rcog.3111
- Mac-Bride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clin Proc 2010; 85(1):87-94. DOI: https://doi.org/10.4065/mcp.2009.0413
- Espitia-De La Hoz FJ, Orozco-Gallego H. Estriol vs estrógenos conjugados de origen equino en el tratamiento del síndrome genitourinario de la menopausia. Ginecol Obstet Mex 2018; 86(2):117-126. DOI: https://doi.org/10.24245/gom.v86i2.1881
- Espitia-De La Hoz FJ, Orozco-Gallego H. Abordaje diagnóstico y terapéutico del síndrome genitourinario en la menopausia; actualización. Rev Med UCR 2017; 11(2):67-84. DOI: https://doi.org/10.15517/rmucr.v11i2.34580
- Coelingh-Bennink HJ. Are all estrogens the same? Maturitas 2004; 47(4):269-275. DOI: https://doi.org/10.1016/j.maturitas.2003.11.009
- Espitia-De La Hoz FJ, Orozco-Gallego H. Evaluación de la eficacia de dos terapias estrogénicas locales más un lubricante vaginal, para el control de los síntomas del síndrome genitourinario de la menopausia. Rev. Investigaciones Andina 2019; 38(21):167-183. DOI: https://doi.org/10.33132/01248146.998
- Espitia-De La Hoz FJ, Orozco-Gallego H, Echeverri-Ocampo LM. Terapia hormonal y no hormonal en la vaginitis atrófica posmenopáusica: curay satisfacción a mediano y a largo plazo de los síntomas. Rev Col de Menopausia 2016; 22(1):8-17.
- Espitia-De La Hoz FJ. Efficacy and tolerance of policresulen in the treatment of the genitourinary syndrome of menopause. Int J Fam Commun Med 2019; 3(3):132-136. DOI: https://doi.org/10.15406/ijfcm.2019.03.00145
- Isidori AM, Pozza C, Esposito K, Giugliano D, Morano S, Vignozzi L, et al. Development and validation of a 6-item version of the female sexual function index (FSFI) as a diagnostic tool for female sexual dysfunction. J Sex Med 2010; 7(3):1139-1146. DOI: https://doi.org/10.1111/j.1743-6109.2009.01635.x
- Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000; 26(2):191-208. DOI: https://doi.org/10.1080/009262300278597
- Espitia- De La Hoz FJ. Dispositivo EROS en el manejo de la anorgasmia femenina: Estudio prospectivo de serie de casos en mujeres del Quindío. Univ Salud 2019; 21(1):38-47. DOI: http://dx.doi.org/10.22267/rus.192101.138
- Lee Y, Lim MC, Joo J, Park K, Lee S, Seo S, et al. Development and validation of the Korean version of the Female Sexual Function Index-6 (FSFI-6K). Yonsei Med J 2014; 55(5):1442-1446. DOI: https://doi.org/10.3349/ymj.2014.55.5.1442
- Bachmann GA, Notelovitz M, Kelly SJ, Thompson C, Owens A. Long-term non-hormonal treatment of vaginal dryness. Clin Pract Sexuality 1992; 8:3-8.
- Bachmann G. Urogenital ageing: an old problem newly recognized. Maturitas 1995; Suppl(1):S1–S5. DOI: https://doi.org/10.1016/0378-5122(95)00956-6
- Patetico AQ, Reyes LD, Rey-Matias CJ. Comparison of the operative and post operative outcome between episiorrhaphy with and without application of policresulen solution. PJOG. 2016; 40(2):12-19.
- American College of Obstetricians and Gynecologists: ACOG Practice Bulletin No. 141. management of menopausal symptoms. Obstet Gynecol 2014; 123:202-216. DOI: https://doi.org/10.1097/01.AOG.0000441353.20693.78
- The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause 2017; 24(7):728-753. DOI: https://doi.org/10.1097/GME.0000000000000921
- Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee JLong-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2017; 1:CD004143. DOI:
- https://doi.org/10.1002/14651858.CD004143.pub5
- Espinosa DJ. Analytical review of multicenter studies with polycresulene for hemorrhoidal pathologies. Acta Gastroenterol Latinoam. 2000; 30(3):177-186.
